Biovian wins export award for international growth
Press Release | Biovian Ltd
JANUARY 30, 2018
Turku, Finland: – Specialist biopharmaceutical CDMO Biovian has won an export excellence award for its achievements in gaining new markets and sales.
The International Commission for the International Chamber of Commerce of Turku has granted its 2017 Export Excellence Award to Biovian Oy in recognition of its achievements in gaining new markets across Europe, the USA and South Korea.
The Committee aims to highlight inspiring examples of Finnish-based companies who are internationally successful.
“The main criteria for getting the prize are export share of net sales and export growth. The award-winning company must also demonstrate that the trend continues to be positive and that it is a major player in its own field at a global level,” commented International Commission Chairman, Matti Löyttyniemi.
“Biovian Oy clearly meets these criteria, said Mr. Löyttyniemi.”
Turku-based Biovian Oy is a biotechnology company offering its customers the contract manufacturing, analysis and process development of biotechnological medicines and preparations.
Since its foundation in 2003 Biovian has grown to a strong organization with around 80 percent of turn-over generated from exports.
The company’s largest export countries are the Nordic countries, the United Kingdom and Germany. The company also has customer relationships in South Korea and the United States.
Biovian CEO, Dr. Knut Ringbom, said building export markets had been demanding but rewarding.
“The growth of the company has been a kind of snowball effect in which good customer experiences bring in more new customers,” Dr. Ringbom reflected.
Dr. Ringbom revealed that Biovian now plans to expand its premises at the Turku Science Park in Kupittaa, Turku, Finland.
“Expansion analysis suggests that we now have potential capacity to manage more projects simultaneously in the future. However, we will also need to recruit more staff, “Dr. Ringbom added.
Biovian Ltd. is a one-stop-shop Contract Manufacturing Organization (CMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 3,400 square meter facilities in Turku, Finland, that are EMA and FDA certified for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and master cell banking. It also offers labelling, packaging, storage and QP release services.
Biovian also provides development services that cover cell line, process and analysis.
Name: Antti Nieminen, Director, Business Development and Projects, Biovian Ltd.
Tel: +358 40 502 1332